In January 2019 Solentim, a global leader in cell line development (CLD) instrumentation, and bioengineering company ATUM, announced a technology partnering and collaboration agreement to enable rapid, high expression, stable cell line development. But what exactly are the tangible benefits gained from both parties and for customers, and why does this fusion of technology offer more …
NEWS – Bournemouth, UK – 14th January 2019: Solentim, a global leader in cell line development instrumentation, and bioengineering company ATUM, today announced a technology partnering and collaboration agreement. This agreement creates the most efficient cell line development solution for biotherapeutic drug developers yet, by integrating Solentim’s VIPS™ (verified in-situ plate seeding) hardware for isolating single …
Never far from scientific and mainstream news, CRISPR is regularly hailed as one of the most important scientific discoveries of our time. With potential applications across wide-ranging fields from medicine to agriculture, being able to control gene expression could provide treatments for a number of genetic diseases and solve global food shortages in times of …
Read more Why is a clonally pure cell line so important in CRISPR research?
Solentim named as one of the top 50 fastest growing UK technologies companies of 2018 16th November 2018 / Solentim, a life sciences company, has won a place in this year’s Deloitte’s UK Technology Fast 50 list following a 1,106% revenue growth over the past 4 years. Solentim specialises in products used by developers of new …
Read more Solentim Wins Place in Deloitte UK Technology Fast 50
Solentim’s business excellence and expertise in cell line development recognised with awards, for both International Trade and Innovation Wimborne, UK, 8th October 2018 / Solentim, a leading provider of instrumentation used by biopharma companies in the fields of mammalian cell line development and cell culture, has received two Queen’s Awards for Enterprise, one for International Trade and one …
